The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Changes In Market Value Are Expected For The Antibody Discovery Market Over The 2026–2030 Period?
The antibody discovery market has shown robust expansion over recent years. Its size is set to increase from $9.78 billion in 2025 to $10.75 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.8%. The historical development of this market is attributable to several factors, including heightened R&D investments in antibody discovery, the increasing occurrence of infectious and chronic diseases, advancements in hybridoma technology, governmental financial support for biotechnology research, and collaborative efforts between academic institutions and pharmaceutical firms.
The antibody discovery market is projected for substantial growth over the next few years, with its size forecast to reach $15.79 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This expansion during the forecast period is primarily driven by the increasing demand for personalized medicine, the adoption of AI and ML in drug discovery, the expanding biologics market, the integration of high-throughput screening platforms, and a growing emphasis on immunotherapy and targeted therapies. Significant trends anticipated for this period include high-throughput screening techniques, advancements in monoclonal antibodies, the development of personalized antibody therapeutics, multi-specific antibody development, and synthetic antibody engineering.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp
What Key Drivers Are Fueling The Growth Of The Antibody Discovery Market?
The increasing demand for precision therapeutics is anticipated to fuel the expansion of the antibody discovery market in the future. Precision therapeutics, also referred to as personalized therapeutics, involves tailoring medical treatment strategies and interventions to align with the unique characteristics of individual patients. Within precision therapeutics, antibody discovery plays a crucial role by facilitating the creation of targeted therapies, including monoclonal antibodies. These therapies are engineered to specifically and precisely engage with disease-associated molecules or cells, leading to more efficacious and personalized treatment outcomes. As an illustration, in March 2024, data from IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries, indicated that worldwide expenditure on cell and gene therapies escalated to $5.9 billion in 2023, marking a 38% rise compared to 2022. Consequently, the expanding necessity for precision therapeutics is set to propel the growth of the antibody discovery market.
Which Segment Classifications Are Used In The Antibody Discovery Market Segment Analysis?
The antibody discovery market covered in this report is segmented –
1) By Methods: Phage Display, Hybridoma, Other Methods
2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory
Subsegments:
1) By Phage Display: Selection And Screening Techniques, Optimization Methods
2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes
3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques
What Trends Are Shaping The Future Of The Antibody Discovery Market?
Leading companies within the antibody discovery market are implementing cutting-edge technologies, such as AI-driven computational platforms, to boost the efficiency and precision of antibody development. An AI-based computational antibody drug discovery platform utilizes artificial intelligence and various computational methods to quickly identify and optimize therapeutic antibodies. For example, in October 2023, SwiftPharma BV, a Belgium-based firm specializing in recombinant proteins from a plant-based system, introduced an AI-powered antibody discovery platform. This advanced tool integrates artificial intelligence, big data, machine learning, and phage display techniques to rapidly predict high-specificity and high-affinity antibody-antigen binding. This method, which resembles natural language processing, generates diverse antibody variations, thereby enabling SwiftPharma to efficiently establish comprehensive antibody libraries. The entire sophisticated system significantly accelerates the discovery of potential antibody drugs.
Which Firms Are Contributing To The Antibody Discovery Market Ecosystem?
Major companies operating in the antibody discovery market are Charles River Laboratories, WuXi Biologics, Genmab A/S, Evotec, ChemPartner, Aragen Life Science Pvt. Ltd., GenScript Technology Corporation, Biocytogen, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A., Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio Technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico
Get The Full Antibody Discovery Market Report:
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report
Which Region Leads The Antibody Discovery Market In Overall Market Size?
North America was the largest region in the antibody discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Antibody Discovery Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report
Browse Through More Reports Similar to the Global Antibody Discovery Market 2026, By The Business Research Company
Antibody Discovery Market Report 2026
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report
Research Antibodie And Reagent Market Report 2026
Next Generation Antibody Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model